open access

Vol 15, No 2 (2020)
Original Papers
Published online: 2020-03-28
Get Citation

Intercurrent illnesses in patients with multivalvular heart disease.

Sebastian Sawonik, Marek Prasał
DOI: 10.5603/FC.2020.0019
·
Folia Cardiologica 2020;15(2):107-113.

open access

Vol 15, No 2 (2020)
Original Papers
Published online: 2020-03-28

Abstract

Introduction. Multivalvular heart disease has congenital or acquired etiology (e.g. rheumatic fever, atherosclerosis, calcification of the valves, remodeling and dilatation of ventricles). The basis of valvular degeneration is failure of endothelial tissue. The consequence of a long-standing heart defect is a progressive heart failure (HF). The aim of the study is to emphasize that the heart failure and the atrial fibrillation are frequently related to the combined valvular disease. Material and methods. The study involves documentation of 109 patients with a compound heart defect treated from 2006 to 2016. Other factors which were considered in the statistical calculation are: heart failure classified in NYHA scale, presence of a cardiac infarction, diabetes, MAS syndrome, obesity, circulatory arrest, dyspnea, chest pain, fatigability, unconsciousness, dizziness and performed cardioversion. Results. Heart failure neither correlated with a valvular disease (p > 0,05) nor with fainting (p=0,9). Furthermore there was no correlation between HF and heart infarct or coronary arterial disease. Authors can find no dependency between grade of HF (NYHA 2-4) and diabetes mellitus. Conclusions. The risk for the development of these diseases in the research group is much higher than in general population. It is essential to pay special attention to the concomitance heart failure, the atrial fibrillation and valvular diseases.

Abstract

Introduction. Multivalvular heart disease has congenital or acquired etiology (e.g. rheumatic fever, atherosclerosis, calcification of the valves, remodeling and dilatation of ventricles). The basis of valvular degeneration is failure of endothelial tissue. The consequence of a long-standing heart defect is a progressive heart failure (HF). The aim of the study is to emphasize that the heart failure and the atrial fibrillation are frequently related to the combined valvular disease. Material and methods. The study involves documentation of 109 patients with a compound heart defect treated from 2006 to 2016. Other factors which were considered in the statistical calculation are: heart failure classified in NYHA scale, presence of a cardiac infarction, diabetes, MAS syndrome, obesity, circulatory arrest, dyspnea, chest pain, fatigability, unconsciousness, dizziness and performed cardioversion. Results. Heart failure neither correlated with a valvular disease (p > 0,05) nor with fainting (p=0,9). Furthermore there was no correlation between HF and heart infarct or coronary arterial disease. Authors can find no dependency between grade of HF (NYHA 2-4) and diabetes mellitus. Conclusions. The risk for the development of these diseases in the research group is much higher than in general population. It is essential to pay special attention to the concomitance heart failure, the atrial fibrillation and valvular diseases.
Get Citation

Keywords

Mixed valvular disease, heart failure, atrial fibrillation.

About this article
Title

Intercurrent illnesses in patients with multivalvular heart disease.

Journal

Folia Cardiologica

Issue

Vol 15, No 2 (2020)

Pages

107-113

Published online

2020-03-28

DOI

10.5603/FC.2020.0019

Bibliographic record

Folia Cardiologica 2020;15(2):107-113.

Keywords

Mixed valvular disease
heart failure
atrial fibrillation.

Authors

Sebastian Sawonik
Marek Prasał

References (17)
  1. Stanisz-Kempa J, Kukulski T, Gąsior Z. Postępowanie w wadach wielozastawkowych. Kardiologia po Dyplomie. 2014; 13(7–8): 36–45.
  2. Dziedzic H, Podolec P. Komentarz do: „Zmiany w epidemiologii i historia naturalna wad zastawkowych serca”. Medycyna po Dyplomie. [rok?]; 19(9): 31–32.
  3. Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol. 2000; 35(6): 1628–1637.
  4. Karasek D, Kubica A, Sinkiewicz W, et al. Epidemia niewydolności serca — problem zdrowotny i społeczny starzejących się społeczeństw Polski i Europy. Folia Cardiol Excerpta. 2008; 3(5): 242–248.
  5. Mitkowski P. Niewydolność serca — epidemia XXI wieku. Choroby Serca i Naczyń. 2004,; 1(1): 43–50.
  6. Nessler J, Windak A, Oleszczyk M, et al. Zasady postępowania w niewydolności serca – Wytyczne Kolegium Lekarzy Rodzinnych w Polsce oraz Sekcji Niewydolności Serca Polskiego Towarzystwa Kardiologicznego. Medycyna Praktyczna. Lekarz Rodzinny. Wydanie specjalne 2/2017. https://ptmr.info.pl/wp-content/uploads/Zasady-post%C4%99powania-w-niewydolno%C5%9Bci-serca-2017.pdf (August 18, 2018).
  7. McMurray JJV, Adamopoulos S, Anker SD, et al. Wytyczne ESC dotyczące rozpoznania oraz leczenia ostrej i przewlekłej niewydolności serca na 2012 rok. Kardiol Pol. 2012; 70(Suppl II): 101–176.
  8. Ponikowski P, Voors AA, Anker SD, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129–2200.
  9. Gajewski P, Budaj A, Niżankowska-Mogilnicka E. „Interna Szczeklika”. Podręcznik chorób wewnętrznych. Medycyna Praktyczna, Kraków 2016: 395–422.
  10. Kowalczyk B, Czyż R, Kaźmierska B. Heart failure — definition, classification, epidemiology, symptoms and treatment. Journal of Education, Health and Sport. 2016; 6(11): 352–367.
  11. Praska-Ogińska A, Bednarski J. Clinical characteristic of 100 patients from pilot registry of heart failure patients hospitalized in the district hospital in Poland. Folia Cardiol. 2017; 12(4): 337–341.
  12. Ponikowski P, Voors AA, Anker SD, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129–2200.
  13. Praska-Ogińska AM, Bednarski J. Leczenie ostrej niewydolności serca. Folia Cardiol. 2017; 12(3): 306–316.
  14. Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997; 96(7): 2455–2461.
  15. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994; 271(11): 840–844.
  16. Dłużniewski M, Syska-Sumińska J, Kalarus Z. Migotanie przedsionków. Codzienność lekarza praktyka. Czelej, Lublin 2016: 37–52.
  17. Kirchhof P, Benussi S, Kotecha D, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37(38): 2893–2962.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl